Theraclion SA
EPA:ALTHE.PA
0.38 (EUR) • At close November 8, 2024
Overzicht | Financiële gegevens
Bedrijfsnaam | Theraclion SA |
Symbool | ALTHE.PA |
Munteenheid | EUR |
Prijs | 0.375 |
Beurswaarde | 16,725,323 |
Dividendpercentage | 0% |
52-weken bereik | 0.286 - 0.68 |
Industrie | Medical Devices |
Sector | Healthcare |
CEO | Mr. David Auregan |
Website | https://www.theraclion.com |
An error occurred while fetching data.
Over Theraclion SA
Theraclion SA develops echotherapy solutions using high intensity focused ultrasound system. It offers SONOVEIN, a robotic solution for non-invasive echotherapy treatment of varicose veins; ECHOPULSE, a robotic and non-invasive solution for echotherapy treatment of thyroid nodules and breast fibroadenoma; and EPack, a disposable that is installed on the device before
Vergelijkbare Aandelen
Financiële Gegevens
Cijfers zijn in miljoenen (EUR)
Cijfers zijn in miljoenen (EUR)